NEW TARGETED PAIN RELIEF
Planticin formulation combines the powerful analgesic Lidocaine with anti-inflammatories
in a targeted transdermal delivery vehicle that promotes deep tissue penetration and provides
quick and lasting pain relief. In a recent clinical study, Planticin reduced pain scores an average
of 64% in 2 weeks and 90% of patients experienced significant pain relief after 1 application.
Planticin is sold as an over-the-counter product exclusively to healthcare practitioners for
dispensing to their patients. It is not sold in pharmacies or on the Internet.